The Risks of Percutaneous Native Kidney Biopsy in Italy: a Prospective Cohort Study

CompletedOBSERVATIONAL
Enrollment

5,304

Participants

Timeline

Start Date

January 3, 2012

Primary Completion Date

August 4, 2020

Study Completion Date

May 31, 2021

Conditions
Kidney Diseases
Interventions
PROCEDURE

Native kidney biopsy

Trial Locations (18)

Unknown

San Giovanni di Dio Hospital, Agrigento

Giovanni XXIII pediatric Hospital, Bari

Policlinico Hospital, Bari

S. Orsola Hospital, Bologna

Cannizzaro Hospital, Catania

S. Camillo Hospital, Chieti

Santa Croce Hospital, Cuneo

Maria SS. Addolorata Hospital, Eboli

University Hospital, Foggia

Policlinico Hospital, Messina

Cervello Hospital, Palermo

Riuniti Hospital, Parma

Ospedali Riuniti Marche Nord Hospital, Pesaro

Cisanello Hospital, Pisa

Umberto 1° Hospital, Roma

Istituto Clinico Humanitas, Rozzano

Sollievo Sofferenza Hospital, San Giovanni Rotondo

Belcolle Hospital, Viterbo

All Listed Sponsors
lead

Simeone Andrulli, MD

OTHER

NCT04948593 - The Risks of Percutaneous Native Kidney Biopsy in Italy: a Prospective Cohort Study | Biotech Hunter | Biotech Hunter